Skip to main content

For adults with active non-radiographic axial spondyloarthritis

Purple to pink gradient background
40% overall symptom improvement in as little as 16 weeks

Many people taking COSENTYX saw at least a 40% improvement in overall symptoms in as little as 16 weeks, with many continuing to see similar results at 1 year.‡,*,**

41% of people taking COSENTYX vs 28% taking placebo.
38% of people taking COSENTYX vs 19% taking placebo.
*Administered subcutaneously (under your skin).
**All results shown in clinical trials using subcutaneous (SC) administration (injection under the skin). The FDA approval of the intravenous (IV) administration (injected into a vein) of COSENTYX is based on data showing that the amount of the medication in your body after it is given directly through IV was within the range that would be seen when given as SC.

ǁBath Ankylosing Spondylitis Disease Activity Index.

COSENTYX may improve your mobility to help make it easier to do daily activities.

In a clinical trial, at 16 weeks, people taking COSENTYX for non-radiographic axial spondyloarthritis showed overall mobility improvement based upon the total average score of all responses from a questionnaire that asked how difficult it was to perform daily activities, such as:

  

Bending from the waist

Bending from the waist

Dribbling basketball

Doing physically demanding activities (such as gardening or sports)

Cutting Hair

Doing a full day of activities at work or home

Climbing 12 - 15 steps

Climbing 12–15 steps without using a handrail or walking aid

*Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.